SR 11302 是激活蛋白-1 (AP-1) 转录因子抑制剂。SR 11302 是一种类视黄醇,可特异性抑制 AP-1 活性,而不会激活视黄酸反应元件 (RARE) 的转录。
生物活性 | SR 11302 is anactivator protein-1(AP-1) transcription factor inhibitor. SR 11302 is a retinoid that specifically inhibitsAP-1activity without activating the transcription of retinoic acid response element (RARE)[1]. |
IC50& Target | |
体外研究 (In Vitro) | SR 11302 (SR11302) show strong anti-AP-1 activity with selective binding with RARα and RARγ, but not with RARβ and RXRα[1]. SR 11302 (SR-11302; 1 μM) inhibits AP-1 transcription factor activity and decreases aldosterone levels by 61.9% in hypoxia-treated cells[2]. SR 11302 (SR-11302; 2 μM; 48 hours) inhibitsHelicobacter pylori(H. pylori)-induced cell proliferation in adenocarcinoma gastric (AGS) cells[3]. SR 11302 (2 μM; 24 hours) inhibitsH. pylori-induced expression of β-catenin and c-myc in AGS cells[3].
|
体内研究 (In Vivo) | SR 11302 (SR11302; low dose 0.5 mg/kg and high dose 1 mg/kg body weight; orally gavaged daily) treatment reduces the total vascular lesion number and lesion size inVldlr-/-mice in a dose-dependent manner[4].
Animal Model: | Vldlr-/-mice[4] | Dosage: | Low dose 0.5 mg/kg and high dose 1 mg/kg body weight | Administration: | Orally gavaged daily from P5 to P15 | Result: | High-dose from P5 to P15 reduced the total vascular lesion number by 48% and decreased the lesion size by 40%, without detectable signs of toxicity in mice, including no change in body weight. |
|
分子量 | |
性状 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Powder | -20°C | 3 years | In solvent | -80°C | 6 months | | -20°C | 1 month |
|
溶解性数据 | In Vitro: DMSO : 25 mg/mL(66.40 mM;ultrasonic and warming and heat to 80℃) 配制储备液 1 mM | 2.6558 mL | 13.2792 mL | 26.5583 mL | 5 mM | 0.5312 mL | 2.6558 mL | 5.3117 mL | 10 mM | 0.2656 mL | 1.3279 mL | 2.6558 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百 分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 1. 请依序添加每种溶剂: 10% DMSO 90% (20%SBE-β-CDin saline) Solubility: 2.5 mg/mL (6.64 mM); Suspended solution; Need ultrasonic
此方案可获得 2.5 mg/mL (6.64 mM) 的均匀悬浊液,悬浊液可用于口服和腹腔注射。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。
*以上所有助溶剂都可在本网站选购。 |